Guideline Recommendations Offer No OS Benefit for Younger Patients With Rectal Cancer
A retrospective review of data from the National Cancer Data Base demonstrated that trends in rectal cancer may follow a pattern similar to that of colon cancer.
Diagnosis & Disease Information
Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
A new analysis of FAB/LMB 96 looked into factors associated with shortened OS among children and adolescents with B-NHL.
QOL, Fatigue, but Not Physical Performance, Return to Normal After AML Treatment
In a prospective, longitudinal study, researchers investigated the potential for quality of life, fatigue, and physical functioning to return to previous levels in patients with AML after treatment.
Radiotherapy Outcomes Improved When Breast Cancer CTCs Detectable
Researchers explored connections between overall survival and adjuvant radiotherapy when factoring in CTC status.
Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial
Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.
No Improvement in OS, DFS With MP + Adjuvant ADT for High-Risk Prostate Cancer
The addition of mitoxantrone and prednisone (MP) to adjuvant androgen-deprivation therapy did not increase survival among patients with high-risk prostate cancer.
Dose-Dense Chemotherapy for Breast Cancer May Impair Lung Function
Long-term analysis determined the effect of postadjuvant dose-dense chemotherapy on DLCO among women with breast cancer.
Novel Agents Plus Paclitaxel, Carboplatin, Does Not Improve Survival in Endometrial Cancer
A phase 2 study determined if adding bevacizumab or temsirolimus to PC, or an ixabepilone/carboplatin/bevacizumab combination will increase progression-free survival for women with advanced/recurrent endometrial cancer, compared with PC alone.
Low-fat Diet May Improve Overall Survival in Newly Diagnosed Breast Cancer
In a follow-up to the Women’s Health Initiative study, researchers determined the effect of a low-fat diet on overall survival after a breast cancer diagnosis.
Primary Cytoreductive Surgery for HGSC Offers Better Survival Than Neoadjuvant Chemotherapy
Researchers conducted a retrospective cohort analysis to examine patterns of clinical practice in the management of women with advanced HGSC.
- Loading...
Loading...
Next post in Ovarian Cancer
Loading... 
Loading...